Double-Blind Randomized Controlled Clinical Trial of the Interleukin-6 Receptor Antagonist, Tocilizumab, in European Patients With Rheumatoid Arthritis Who Had an Incomplete Response to Methotrexate
2017 ◽
Vol 15
(4)
◽
pp. 445-451
◽
2020 ◽
Vol 29
(3)
◽
pp. 311-326
◽